Project Grant HT94252510968
Award Date 9/30/25
Completion Date 9/29/29
Dollars Obligated $6.8M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
- This Project Grant award of $731,980.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Regents of the University of Michigan. The award will fund a research project titled "A DATA-DRIVEN APPROACH TO INDIVIDUALIZED CONCUSSION RISK PREDICTION IN U.S. SERVICE ACADEMY CADETS AND MIDSHIPMEN" from August 1, 2024 to July 31, 2027. The project aims to develop an individualized concussion risk prediction model for...
- The University of Michigan will receive $1.5 million from the Department of the Army Medical Command under a three-year Project Grant award to support biomarker-guided brain CT imaging research in traumatic brain injury. The grant, issued under the Military Medical Research and Development program (CFDA 12.420), will fund efforts from September 2022 to September 2025 to investigate medical solutions for traumatic brain injuries on the battlefield through innovative and impactful research that...
- This $248,156 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by the Regents of the University of Michigan to identify molecular biomarkers for invasive glioblastoma cell states and tumor microenvironment modulation. The award period is from October 1, 2025 to September 30, 2027. As a major research university, the University of Michigan has a diverse portfolio of federal contract and grant awards,...
- The Defense Health Agency awarded a $1,178,939.00 Project Grant to the Regents of the University of Michigan under the Military Medical Research and Development program (CFDA 12.420) to conduct advanced phenotyping research to improve diagnostic, longitudinal assessment, and treatment strategies for deployment-related respiratory disease. The award period is from September 1, 2023 to August 31, 2026. As a U.S. Government Entity and top public research university, the University of Michigan has...
- The Regents of the University of Michigan received a $312,000.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The 2-year grant, awarded on February 1, 2024, supports research to investigate "An Unexpected Role for the Ubiquitin Proteasome System in Repeat Associated Non-AUG Translation." This basic and translational biomedical research aims to advance understanding and treatment of neurological disorders...
- This $780,000 Project Grant was awarded on August 1, 2025 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Regents of the University of Michigan. The grant will support a 3-year research project titled "Lead Exposure and Sex-Specific Programming of Cardiovascular Disease Across the Life Course" focused on advancing biomedical research to transform healthcare for military service members, veterans, and the public. The...
- The Department of Defense's Defense Health Agency awarded a $1,100,747 Project Grant on April 1, 2025 to the Regents of the University of Michigan to conduct research on "Protein Engineering of Antibody-Drug Conjugates to Coordinate the Innate and Adaptive Immune Systems for Curative Responses" under the Military Medical Research and Development program (CFDA 12.420). This research aims to develop innovative medical solutions that address critical health challenges relevant to military...
- The University of Michigan received a $932,498 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct non-invasive central nervous system delivery of immunocytokines for sustained expansion of regulatory T cells and treatment of amyotrophic lateral sclerosis (ALS). The award period runs from June 1, 2025 to May 31, 2027. This research aims to develop innovative medical solutions that address critical health...
- This $320,000.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by the Regents of the University of Michigan to investigate the impact of the integrated stress response on visual synaptic circuits in multiple sclerosis. The research, to be conducted from September 1, 2025 to August 31, 2027, aims to advance the understanding of disease mechanisms and develop potential therapeutic solutions for this...
- The federal Project Grant award of $537,536.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to the Regents of the University of Michigan is funding research to "TARGET MYCOBIOME METABOLISM TO REPROGRAM THE IMMUNOSUPPRESSIVE PANCREATIC TUMOR MICROENVIRONMENT". The award has a performance period from November 1, 2025 to October 31, 2028 and aims to transform healthcare for military service members, veterans, and the broader public...